Cardiovascular Systems, Inc. Announces Sachin H. Jain, MD, MBA, Joins Board of Directors
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical
device company developing and commercializing innovative
interventional treatment systems for patients with peripheral and
coronary artery disease, today announced the addition of
independent board member Sachin H. Jain, MD, MBA.
Dr. Jain is currently President and Chief Executive Officer of
SCAN Group and Health Plan, a mission-driven organization dedicated
to the health and wellness of older adults. Prior to this role, he
was President and Chief Executive Officer of CareMore and Aspire
Health. Before CareMore, Dr. Jain was Chief Medical Information
& Innovation Officer at Merck & Co. Prior to this role, Dr.
Jain worked in leadership roles at the U.S. Department of Health
and Human Services.
Dr. Jain is an adjunct professor of medicine at the Stanford
University School of Medicine. In addition, Dr. Jain is a respected
thought leader in health care delivery and has been recognized as a
“Top 50 Most Influential Clinical Leader” and “100 Most Influential
People in US Healthcare” by Modern Healthcare. He currently serves
as a member of the board of directors for America’s Health
Insurance Plans, Abode Hospice, and the Make-A-Wish Foundation. He
also serves as an Aspen Institute Health Innovator’s Fellow.
Dr. Jain graduated from Harvard College with a BA in government
and continued on to earn his MD from Harvard Medical School and MBA
from Harvard Business School.
“We are pleased to welcome Dr. Sachin Jain as a new independent
director to the CSI board,” said Scott Ward, Chairman, President
and Chief Executive Officer. “Sachin’s innovation and leadership in
clinical practice, health policy, healthcare delivery and digital
health will expand our Board’s understanding of key opportunities
to prevent amputations and address disparities in healthcare.”
CSI’s board routinely reviews its composition to ensure it
includes the necessary skills, experience and perspective to direct
its business objectives. With the addition of Dr. Jain, four
independent directors have joined CSI’s board since July 2019. The
CSI board is comprised of nine directors, eight of whom are
About Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a
medical device company focused on developing and commercializing
innovative solutions for treating vascular and coronary disease.
The company’s orbital atherectomy system treats calcified and
fibrotic plaque in arterial vessels throughout the leg and heart
and addresses many of the limitations associated with existing
surgical, catheter and pharmacological treatment alternatives. For
additional information, please visit www.csi360.com and connect on
version on businesswire.com: https://www.businesswire.com/news/home/20210127005040/en/
Cardiovascular Systems, Inc. Jack Nielsen (651) 202-4919